Dr. Heidi A. Erlacher

Partner
Full contact info

Experience

HealthCare Royalty and Blue Owl Announce $250 Million Debt Financing With TG Therapeutics

August 6, 2024

Cooley advised Blue Owl Capital (NYSE: OWL), a top asset manager that is redefining alternatives, and HealthCare Royalty (HCRx), a top royalty acquisition company focused on commercial or near-commercial biopharmaceutical products, on a $250 million term loan facility with TG Therapeutics (NASDAQ: TGTX), a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Mischi a Marca
Partner, San Francisco
Addison Pierce
Associate, Chicago
Geoffrey Spolyar
Partner, Boston
Dr. Jon Cousin
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Michael Egan
Partner, Washington, DC
Dr. Heidi A. Erlacher
Partner, Boston
Steve Flores
Partner, Chicago
Phil Mitchell
Partner, New York
Jason Savich
Partner, San Francisco
Daniel Shamah
Partner, New York
Lei Shen
Partner, Chicago
Shimeng Cheng
Special Counsel, San Francisco
Susan Piascik Christoff
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Amanda Pacheco
Associate, Palo Alto
Dr. Jordan Phelan
Associate, Washington, DC
Matt Kong
Associate, San Francisco
Allison Kutner
Associate, New York
Sarah Miller
Associate, New York
Rodrigo Huerta
Associate, Chicago
Stevie Yu
Associate, New York
Yichao Zhang
Associate, New York

Related Practices & Industries

Sagimet Biosciences Announces Upsized $85 Million IPO

July 18, 2023

Cooley advised the underwriters in the upsized initial public offering of Sagimet Biosciences, a clinical-stage biotechnology company, at $85 million.

Read more

Related contacts

John McKenna
Partner, Palo Alto
Natalie Karam
Partner, Palo Alto
Denny Won
Partner, San Francisco
Dr. Heidi A. Erlacher
Partner, Boston
Natasha Leskovsek
Of Counsel, Washington, DC
David D. Kim
Associate, San Francisco
Victoria Comesañas
Associate, Palo Alto
Dr. Thomas "TJ" Paxton
Associate, Boston
Kate Walther
Paralegal Specialist, San Diego

Related Practices & Industries

VectivBio to be Acquired by Ironwood

May 23, 2023

Cooley advised VectivBio, a clinical-stage biotech company focused on the discovery and development of treatments for severe, rare gastrointestinal (GI) conditions, on its acquisition by Ironwood, with an estimated aggregate consideration of approximately $1 billion.

Read more

Related contacts

Brandon W. Fenn
Partner, New York
Rita Sobral
Special Counsel, London
Sydney Sawyier
Associate, London
Sarah Curry
Associate, New York
Trevor Bossi
Associate, Boston
Lois NaYeon Yoo
Associate, New York
Ofir Hadari
Associate, New York
David Burns
Special Counsel, Washington, DC
Nicollette R. Kirby
Associate, Washington, DC
Barbara Mirza
Partner, Santa Monica
Steven A. Zuckerman
Associate, New York
Stephanie Gentile
Partner, New York
Eileen Marshall
Partner, Washington, DC
Rick Jantz
Associate, Santa Monica
Dr. Heidi A. Erlacher
Partner, Boston
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Megan Flynn
Associate, London
Anthony Hajj
Associate, New York

Related Practices & Industries

CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion

January 10, 2023

Cooley advised CinCor Pharma, a clinical-stage biopharmaceutical company, on its definitive agreement to be acquired by AstraZeneca. M&A partners Rama Padmanabhan and Rowook Park and corporate partners Div Gupta and Sarah Sellers led the Cooley team.

Read more

Related contacts

Rowook Park
Partner, San Diego
Rama Padmanabhan
Partner, San Diego
Div Gupta
Partner, New York
Sarah Sellers
Partner, New York
Christophe Beauduin
Special Counsel, New York
Izzy Lubarsky
Partner, New York
Alessandra Murata
Partner, Palo Alto
Ajay Athavale
Associate, San Francisco
Megan Drill
Associate, San Diego
Trey Reilly
Associate, New York
Amy Hallman Rice
Special Counsel, San Diego
Matthew D. Silverman
Special Counsel, Santa Monica
Howard Morse
Partner, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Rubin Waranch
Associate, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Charity Williams
Partner, San Diego
MaryBeth Shreiner
Special Counsel, Reston
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Karen Tsai
Special Counsel, Washington, DC
Dr. Heidi A. Erlacher
Partner, Boston
Kristopher Kleiner
Special Counsel, Colorado
Ryan Sansom
Partner, Boston
Stephanie Gentile
Partner, New York
Aric Wu
Partner, New York
Christopher Kimball
Partner, Washington, DC
Nyron J. Persaud
Partner, New York
Helenanne Connolly
Partner, Reston
Stella Sarma
Special Counsel, Brussels
Stella Sarma
Special Counsel, Brussels
Stacey A. Bradford
Special Counsel, Washington, DC
Christine Graham
Special Counsel, London
Dillon Martinson
Special Counsel, Washington, DC
Lindsey O'Crump
Associate, Washington, DC
Daniel Gillon
Associate, San Diego
Barry Kuang
Associate, Boston
Rajdeep Roger Bains
Associate, San Diego
Alexander Fullman
Associate, New York
Amanda Gonzalez Burton
Associate, New York
Dr. Xixi Sun
Associate, Boston
Sarah Curry
Associate, New York
Carly Mitchell
Partner, Washington, DC
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York

Related Practices & Industries

Ovid - $75 Million IPO

December 1, 2020

Cooley advised Ovid on its $75 million initial public offering of 5,000,000 shares of common stock. Ovid, which now trades on The NASDAQ Global Select Market as “OVID,” is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders.

Read more

Related contacts

Laura Berezin
Partner, Seattle
Div Gupta
Partner, New York
Jaime L. Chase
Partner, Washington, DC
Sara Semnani
Partner, Santa Monica
Jeramie Perez
Senior Paralegal, Palo Alto
Jason Minio
Paralegal Specialist, Boston
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Dr. Heidi A. Erlacher
Partner, Boston
David Walsh
Partner, Reston
Francis Wheeler
Partner, Colorado

Related Practices & Industries

View more

Admissions and credentials

Massachusetts

US Patent and Trademark Office

Rankings and accolades

Chambers USA: Life Sciences: – Massachusetts (2023 – 2024)

Chambers USA: Intellectual Property – Massachusetts (2023 – 2024)

IAM Patent 1000: Top Patent Lawyer

LMG Life Sciences: “Patent Strategy Attorney of the Year” Finalist (2022)

Super Lawyers: Intellectual Property

Memberships and affiliations

Boston Patent Law Association

American Intellectual Property Law Association